| Accurate quantification of transcriptome from RNA-Seq data by effective length normalization S Lee, CH Seo, B Lim, JO Yang, J Oh, M Kim, S Lee, B Lee, C Kang, ... Nucleic acids research 39 (2), e9-e9, 2011 | 133 | 2011 |
| Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer B Lim, JL Park, HJ Kim, YK Park, JH Kim, HA Sohn, SM Noh, KS Song, ... Carcinogenesis 35 (5), 1020-1027, 2014 | 123 | 2014 |
| Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer B Lim, JH Kim, M Kim, SY Kim World journal of gastroenterology 22 (3), 1190, 2016 | 78 | 2016 |
| Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites B Lim, C Kim, JH Kim, WS Kwon, WS Lee, JM Kim, JY Park, HS Kim, ... Oncotarget 7 (7), 8055, 2016 | 60 | 2016 |
| Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels B Lim, J Mun, JH Kim, CW Kim, SA Roh, DH Cho, YS Kim, SY Kim, JC Kim Oncotarget 6 (26), 22179, 2015 | 45 | 2015 |
| SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse‐type gastric cancer susceptibility H Ju, B Lim, M Kim, SM Noh, WH Kim, C Ihm, BY Choi, YS Kim, C Kang Cancer 116 (18), 4248-4255, 2010 | 43 | 2010 |
| Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3′-shore JL Park, HJ Kim, EH Seo, OH Kwon, B Lim, M Kim, SY Kim, KS Song, ... Oncotarget 6 (35), 37647, 2015 | 36 | 2015 |
| ONECUT2 upregulation is associated with CpG hypomethylation at promoter‐proximal DNA in gastric cancer and triggers ACSL5 EH Seo, HJ Kim, JH Kim, B Lim, JL Park, SY Kim, SI Lee, HY Jeong, ... International Journal of Cancer 146 (12), 3354-3368, 2020 | 29 | 2020 |
| Increased genetic susceptibility to intestinal‐type gastric cancer is associated with increased activity of the RUNX3 distal promoter B Lim, H Ju, M Kim, C Kang Cancer 117 (22), 5161-5171, 2011 | 29 | 2011 |
| Epigenetic silencing of miR‐1271 enhances MEK1 and TEAD4 expression in gastric cancer B Lim, HJ Kim, H Heo, N Huh, SJ Baek, JH Kim, DH Bae, EH Seo, SI Lee, ... Cancer medicine 7 (7), 3411-3424, 2018 | 23 | 2018 |
| Maspin genetically and functionally associates with gastric cancer by regulating cell cycle progression M Kim, H Ju, B Lim, C Kang Carcinogenesis 33 (12), 2344-2350, 2012 | 23 | 2012 |
| A regulatory polymorphism at position-309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression H Ju, B Lim, M Kim, YS Kim, WH Kim, C Ihm, SM Noh, DS Han, HJ Yu, ... Neoplasia 11 (12), 1340-1347, 2009 | 23 | 2009 |
| ANKRD9 is associated with tumor suppression as a substrate receptor subunit of ubiquitin ligase Y Lee, B Lim, SW Lee, WR Lee, YI Kim, M Kim, H Ju, MY Kim, SJ Kang, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (10 …, 2018 | 18 | 2018 |
| Variability in chromatin architecture and associated DNA repair at genomic positions containing somatic mutations B Lim, J Mun, YS Kim, SY Kim Cancer Research 77 (11), 2822-2833, 2017 | 16 | 2017 |
| Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer SA Roh, IJ Park, YS Yoon, YH Kwon, JH Chung, TW Kim, DH Cho, ... Journal of cancer research and clinical oncology 142, 1705-1714, 2016 | 15 | 2016 |
| A guide for bioinformaticians:‘omics-based drug discovery for precision oncology J Mun, G Choi, B Lim Drug discovery today 25 (11), 1897-1904, 2020 | 13 | 2020 |
| Genetic variants A1826H and D2937Y in GAG-β domain of versican influence susceptibility to intestinal-type gastric cancer H Ju, B Lim, M Kim, SM Noh, DS Han, HJ Yu, BY Choi, YS Kim, WH Kim, ... Journal of cancer research and clinical oncology 136, 195-201, 2010 | 12 | 2010 |
| The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia B Lim, D Yoo, Y Chun, A Go, KJ Cho, D Choi, ME Jung, HY Lee, ... Blood Cancer Journal 12 (4), 57, 2022 | 7 | 2022 |
| Intrinsic molecular processes: impact on mutagenesis B Lim, J Mun, SY Kim Trends in Cancer 3 (5), 357-371, 2017 | 5 | 2017 |
| Integrative analyses reveal the anticancer mechanisms and sensitivity markers of the next-generation hypomethylating agent NTX-301 B Lim, D Yoo, Y Chun, A Go, JY Kim, HY Lee, RJ Boohaker, KJ Cho, ... Cancers 15 (6), 1737, 2023 | 2 | 2023 |
